Please wait...

Quick Stats

Offers Claimed:


Downloaded Today:


Daraprim Prescription
view details
Generic Name: pyrimethamine (PIR i METH a meen)
Brand Name: Daraprim
Physician reviewed Daraprim patient information - includes Daraprim description, dosage and directions.
Generic Name: pyrimethamine (PIR i METH a meen)
Brand Name: Daraprim
Physician reviewed Daraprim patient information - includes Daraprim description, dosage and directions.
  • Select Your Prescription Settings
  • X
30 tablets of Daraprim 40 mg
  • Select Your Prescription Settings
  • X

Quick Stats

Offers Claimed: 95

Downloaded Today: 120

Set your location
for drug prices near you

Daraprim Coupons & Prices

Set your location
for drug prices near you

Enter your ZIP Code

Please wait while the prices are loaded...
Click here to try again.

Don’t see your pharmacy listed? Most pharmacies accept our discounts, so have your pharmacist enter this coupon to see if you will save money:

Daraprim Drug Information:

DarAprim is an antiparasite medicine that helps prevent parasites from growing and reproducing in the body. DarAprim is used in adults and children to treat or prevent certain types of malaria. However, this medicine is generally not preferred as a medicine to prevent malaria while traveling. When used to treat malaria, this medicine should be used together with a faster-acting anti-malaria medicine such as chloroquine or quinine. DarAprim is also used to treat toxoplasmosis, an infection caused by the Toxoplasma parasite. Learn more

Daraprim Side Effects

Note: This document contains side effect information about pyrimethamine. Some of the dosage forms listed on this page may not apply to the brand name Daraprim.

For the Consumer

Applies to pyrimethamine: oral tablet

Along with its needed effects, pyrimethamine (the active ingredient contained in Daraprim) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking pyrimethamine:

Less common

  • Black, tarry stools
  • blood in urine or stools
  • cough or hoarseness
  • fever or chills
  • irritation or soreness of tongue
  • lower back or side pain
  • painful or difficult urination
  • pinpoint red spots on skin
  • unusual bleeding or bruising


  • Bleeding or crusting sores on lips
  • chest pain or discomfort
  • muscle cramps or pain
  • redness, blistering, peeling, or loosening of skin
  • skin rash
  • sores, ulcers, and/or white spots in mouth
  • sore throat
  • unusual tiredness or weakness

Frequency not known

  • Blood in urine
  • diarrhea
  • difficulty swallowing
  • dizziness
  • fainting spells
  • fast, slow, or irregular heartbeat
  • hives
  • itching
  • joint or muscle pain
  • lightheadedness
  • pale skin
  • pounding or rapid pulse
  • puffiness or swelling of the eyelids or around the eyes, face, lips or tongue
  • rapid breathing
  • red, irritated eyes
  • red skin lesions, often with a purple center
  • shortness of breath
  • swollen glands
  • tightness in chest
  • unexplained bleeding or bruising
  • wheezing

Symptoms of overdose

  • Abdominal or stomach pain
  • convulsions (seizures)
  • increased excitability
  • vomiting (severe and continuing)

Some side effects of pyrimethamine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common

  • Diarrhea
  • loss of appetite
  • nausea
  • vomiting

For Healthcare Professionals

Applies to pyrimethamine: compounding powder, oral tablet


Since this drug is coadministered with a sulfonamide, the manufacturer product information for the relevant sulfonamide should be consulted for sulfonamide-related side effects.


Very common (10% or more): Nausea, vomiting, diarrhea, colic

Uncommon (0.1% to 1%): Dry mouth, dry throat

Very rare (less than 0.01%): Buccal ulceration

Frequency not reported: Glossitis, atrophic glossitis

Nervous system

Precipitation of a grand mal attack in a patient predisposed to epilepsy was reported; clinical significance was not established.

Very common (10% or more): Headache

Common (1% to 10%): Dizziness

Very rare (less than 0.01%): Convulsions/seizures

Frequency not reported: Ataxia, tremors, precipitation of grand mal attack


Very common (10% or more): Anemia

Common (1% to 10%): Thrombocytopenia, leukopenia

Very rare (less than 0.01%): Pancytopenia

Frequency not reported: Megaloblastic anemia, neutropenia, agranulocytosis


Very common (10% or more): Rash

Uncommon (0.1% to 1%): Abnormal skin pigmentation, dermatitis


Uncommon (0.1% to 1%): Fever, malaise


Insomnia was reported when this drug was given weekly at higher than recommended doses.

Uncommon (0.1% to 1%): Depression

Very rare (less than 0.01%): Insomnia


Rare (0.01% to 0.1%): Pulmonary eosinophilia

Very rare (less than 0.01%): Pneumonia with cellular and eosinophilic pulmonary infiltration

Pneumonia with cellular and eosinophilic pulmonary infiltration was observed when this drug was administered once a week with sulfadoxine.


Frequency not reported: Hypersensitivity reactions (included erythema multiforme, Stevens-Johnson Syndrome, toxic epidermal necrolysis, Lyell's syndrome, hepatitis, anaphylaxis, pulmonary reactions, maculopapular rashes)


Circulatory collapse was reported in patients treated with higher than recommended doses.

Very rare (less than 0.01%): Circulatory collapse

Frequency not reported: Disorders of cardiac rhythm, arrhythmias


Hyperphenylalaninemia was reported in neonates treated for congenital toxoplasmosis.

Very rare (less than 0.01%): Hyperphenylalaninemia

Frequency not reported: Anorexia


Very rare (less than 0.01%): Hematuria


A 51-year-old female developed chronic granulocytic leukemia after taking this drug for 2 years for toxoplasmosis and a 56-year-old patient developed reticulum cell sarcoma after taking this drug for 14 months for toxoplasmosis.

Frequency not reported: Chronic granulocytic leukemia, reticulum cell sarcoma

Editorial References and Review

Medically reviewed by USARx EDITORIAL TEAM Last updated on 1/27/2021.

Source: Drugs.com Daraprim (www.drugs.com/mtm/daraprim.html).